ZyVersa Therapeutics Reports First Quarter, 2024 Financial Results and Provides Business Update
15 mai 2024 08h35 HE
|
ZyVersa Therapeutics
ZyVersa is on track to achieve key development milestones over the next 3 quarters.
ZyVersa Therapeutics Announces Equity Research Coverage Initiated by Noble Capital Markets
04 janv. 2024 07h50 HE
|
ZyVersa Therapeutics
ZyVersa is developing two proprietary product platforms targeting renal and inflammatory diseases. Cholesterol Efflux MediatorTM VAR 200, designed to ameliorate renal lipid accumulation that...
ZyVersa Therapeutics to Participate in a Fireside Chat at Oppenheimer Healthcare Conference
01 mars 2023 09h20 HE
|
ZyVersa Therapeutics
CEO Stephen C. Glover to discuss key updates on the development status of ZyVersa’s Phase 2a-ready Cholesterol Efflux Mediator™ VAR 200 for renal disease, and inflammasome ASC inhibitor IC 100 for...
ZyVersa Therapeutics to Participate in a Fireside Chat at Roth Annual Conference
27 févr. 2023 09h20 HE
|
ZyVersa Therapeutics
CEO Stephen C. Glover to discuss key updates on the development status of ZyVersa’s Phase 2a-ready Cholesterol Efflux Mediator™ VAR 200 for renal disease, and inflammasome ASC inhibitor IC 100 which...
Sigyn Therapeutics Announces First-In-Human Clinical Strategy to Address Inflammation and Endotoxemia in End-Stage Renal Disease Patients
14 sept. 2022 09h00 HE
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Sept. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTCQB: SIGY), a development-stage company focused on the creation of therapeutic solutions that address...
Peripheral Intravenous Catheters Market To Reach USD 7.52 Billion By 2027 | Reports and Data
04 mars 2020 12h00 HE
|
Reports and Data
New York, March 04, 2020 (GLOBE NEWSWIRE) -- The global Peripheral Intravenous Catheters market is forecast to reach USD 7.52 Billion by 2027, according to a new report by Reports and Data....
Nephros Announces $2.9 Million Private Placement
11 avr. 2018 07h30 HE
|
Nephros, Inc.
SOUTH ORANGE, NJ, April 11, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters...
2017 Satellite Healthcare Norman S. Coplon Extramural Grant Program Now Accepting Applications
03 janv. 2017 09h00 HE
|
Satellite Healthcare
SAN JOSE, Calif., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Satellite Healthcare, a leading not-for-profit dialysis care provider, is pleased to announce that the Norman S. Coplon Extramural Grant Program...
CMS Five-Star Quality Rating System Identifies Satellite Healthcare as Leading 10 Largest Dialysis Providers in Percentage of Top-Rated Dialysis Centers
27 oct. 2016 15h31 HE
|
Satellite Healthcare
SAN JOSE, Calif., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Satellite Healthcare today announced that it leads the industry with the highest percentage of top-rated dialysis centers among the 10 largest...
Satellite Healthcare Partners with American Kidney Fund to Support Clinical Research
15 août 2016 09h00 HE
|
Satellite Healthcare
SAN JOSE, Calif., Aug. 15, 2016 (GLOBE NEWSWIRE) -- Satellite Healthcare, a leading not-for-profit dialysis care provider, is pleased to announce that it has joined forces with the American Kidney...